Skip to main navigation Skip to search Skip to main content

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia [2]

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish (US)
Pages (from-to)4291-4292
Number of pages2
JournalBlood
Volume108
Issue number13
DOIs
StatePublished - Dec 15 2006

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this